To study the essential relationship between TME immune status and YTHDF1 level in patients with HCC, we quantitatively analyzed the CD3+ and CD8+ T cell counts with immunofluorescence assay. This evidence concerns the gene YTHDF1 and hepatocellular carcinoma.